Analysis of blinded test samples validated the effectiveness of the biomarkers to discriminate between young and old, and between disease groups (MDS, cirrhosis) and healthy controls.

• 研究人员希望这些标记能在医疗中得到应用，这将使根据病患个体生物学年龄改进治疗成为可能，从而达到更好的效果。